Analyst Activity – Royal Bank of Canada Lowers Its Price Target On NASDAQ:AGRX – Agile Therapeutics (NASDAQ:AGRX) to

ME Staff
-
0

Analyst Ratings For NASDAQ:AGRX – Agile Therapeutics (NASDAQ:AGRX)

Today, Royal Bank of Canada lowered its price target on NASDAQ:AGRX – Agile Therapeutics (NASDAQ:AGRX) to per share.

Some recent analyst ratings include

  • 3/14/2018-Noble Financial Reiterated Rating of Buy.
  • 12/28/2017-Janney Montgomery Scott was Downgraded by analysts at Janney Montgomery Scott from a “Buy ➝ Neutral” rating to a “” rating.
  • 12/26/2017-William Blair was Downgraded by analysts at William Blair from a “Outperform ➝ Market Perform” rating to a “” rating.
  • 12/22/2017-Cantor Fitzgerald Reiterated Rating of Buy.

Recent Insider Trading Activity For NASDAQ:AGRX – Agile Therapeutics (NASDAQ:AGRX)
NASDAQ:AGRX – Agile Therapeutics (NASDAQ:AGRX) has insider ownership of 7.30% and institutional ownership of 72.15%.

  • On 8/25/2017 Alfred Altomari, Chairman, bought 10,000 with an average share price of $3.34 per share and the total transaction amounting to $33,400.00.
  • On 8/25/2017 Renee Selman, Insider, bought 7,250 with an average share price of $3.35 per share and the total transaction amounting to $24,287.50.
  • On 5/11/2017 Alfred Altomari, Chairman, bought 10,000 with an average share price of $3.51 per share and the total transaction amounting to $35,100.00.
  • On 5/11/2017 Renee Selman, Insider, bought 53,333 with an average share price of $3.68 per share and the total transaction amounting to $196,265.44.
  • On 1/27/2016 Jay Moorin, Major Shareholder, bought 393,700 with an average share price of $6.35 per share and the total transaction amounting to $2,499,995.00.
  • On 6/2/2015 Alfred Altomari, CEO, bought 2,500 with an average share price of $8.73 per share and the total transaction amounting to $21,825.00.
  • On 1/23/2015 Jay Moorin, Major Shareholder, bought 811,966 with an average share price of $5.85 per share and the total transaction amounting to $4,750,001.10.

Recent Trading Activity for NASDAQ:AGRX – Agile Therapeutics (NASDAQ:AGRX)
Shares of NASDAQ:AGRX – Agile Therapeutics closed the previous trading session at 0.71 up +0.02 2.90% with 0.699999988079071 shares trading hands.